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Abstract: N-acetylglutamate synthase (NAGS) catalyzes the production of N-acetylglutamate 
(NAG) from acetyl-CoA and L-glutamate. In microorganisms and plants, the enzyme 
functions in the arginine biosynthetic pathway, while in mammals, its major role is to 
produce the essential co-factor of carbamoyl phosphate synthetase 1 (CPS1) in the urea 
cycle. Recent work has shown that several different genes encode enzymes that can 
catalyze NAG formation. A bifunctional enzyme was identified in certain bacteria, which 
catalyzes both NAGS and N-acetylglutamate kinase (NAGK) activities, the first two steps 
of the arginine biosynthetic pathway. Interestingly, these bifunctional enzymes have higher 
sequence similarity to vertebrate NAGS than those of the classical (mono-functional) 
bacterial NAGS. Solving the structures for both classical bacterial NAGS and bifunctional 
vertebrate-like NAGS/K has advanced our insight into the regulation and catalytic 
mechanisms of NAGS, and the evolutionary relationship between the two NAGS groups. 
Keywords: arginine biosynthesis; urea cycle; N-acetylglutamate synthase; crystal structures; 
catalysis and regulation 
 
OPEN ACCESS




N-acetylglutamate (NAG) is the initial precursor of arginine in the arginine biosynthetic pathway in 
microorganisms and plants, while the same compound is an essential cofactor of carbamoyl phosphate 
synthetase 1 (CPS1) in the urea cycle [1–3]. Acetylation of the early precursors of arginine prevents 
the spontaneous cyclization of the semialdehyde with the unprotected α-amino group of glutamate 
separating arginine biosynthesis from proline biosynthesis. The flow of the acetylated precursors  
of arginine often starts with NAG and ends with acetylornithine, identification of the novel  
N-acetylornithine transcarbamylase suggests that the acetylated precursors of arginine extend beyond 
acetylornithine in certain bacteria [4–6]. Deacetylation of acetylornithine to form ornithine is achieved 
by one of two enzymes, either acetylornithine deacetylase (acetylornithinase) in the linear pathway,  
or ornithine acetyltransferase in the cyclic pathway. The cyclic pathway observed in most bacteria  
and plants recycles the acetyl group to form NAG, which is energetically more economical and is  
considered traditionally to have evolved more recently [7]. The formation of arginine is catalyzed by three  
subsequent enzymes, ornithine transcarbamylase, argininosuccinate synthase, and argininosuccinate lyase, 
via citrulline and argininosuccinate. 
Enzymes catalyzing the acetylation of L-glutamate exhibit a high degree of diversity compared to 
the other enzymes of arginine biosynthesis. The best known is the classical bacterial N-acetylglutamate 
synthase (NAGS), which was identified in Escherichia coli and Pseudomonas aeruginosa [8–11].  
This enzyme is encoded by a single gene (argA), and consists of two domains. The N-terminal domain 
is similar to amino acid kinases (AAK), which are also found in the next enzyme of arginine 
biosynthesis, N-acetylglutamate kinase (NAGK). The C-terminal, N-acetyltransferase (NAT) domain 
is a member of the Gcn5-related acetyltransferase (GNAT) family that transfers the acetyl group from 
acetyl-CoA to various amino groups. The protein sequence of members of the GNAT family is highly 
diverse with overall similarities as low as 5%–10%. Even though human and rat NAGS activities have 
been known for more than thirty years [12–14], the mammalian NAGS genes were not identified until 
2002, probably because of the low sequence similarities to bacterial homologues [15,16]. Interestingly, 
some bacterial NAGS-like sequences with higher sequence similarities to mammalian NAGS than to 
classical bacteria NAGS, were also identified in several Xanthomonadales and marine α-proteobacteria. 
Further studies have revealed that these proteins have both NAGS and NAGK activities, catalyzing the 
first two reactions of arginine biosynthesis as a bifunctional NAGS/K enzyme [17,18]. Phylogenetic 
analysis of NAGS sequences from bacteria, fungi, plants and vertebrates demonstrated that classical 
bacteria NAGS and plant NAGS belong to one group (defined as the bacteria-like NAGS group), while 
vertebrate and fungal NAGS and bifunctional NAGS/K cluster into another group (defined as 
vertebrate-like NAGS group), but with higher divergence within the group [17]. Interestingly, fungal 
NAGK also belongs to the vertebrate-like NAGS group, even though it does not have NAGS activity. 
In addition to the above enzymes, which have AAK and NAT domains, several other proteins  
are able to catalyze the formation of NAG (Figure 1). The best-known is argJ encoded ornithine 
acetyltransferase (OAT), which catalyzes the reversible acetyl exchange between ornithine and 
glutamate. OATs have been characterized in vitro or in vivo as mono- or bifunctional enzymes [19,20]. 
The bifunctional OAT catalyzes both the acetyl transfer reaction from acetylornithine to glutamate and 
from acetyl-CoA to glutamate as does the typical NAGS. No detectable sequence similarity is 
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observed between bifunctional OATs and typical NAGS. It seems that the CoA moiety of acetyl-CoA 
does not enter the catalytic site of OAT [19], in contrast to the typical NAGS, which recognizes  
CoA [21]. Mature active OAT derives from a preprotein, which undergoes autocatalytic cleavage to 
form a biologically active hetero tetramer [22,23]. 
 
Figure 1. Enzymes that produce N-acetylglutamate. Bacteria-like N-acetylglutamate 
synthase (NAGS) include the classical bacterial NAGS and plant NAGS, which have 
hexameric architectures, represented by NAGS from Neisseria gonorrhoeae (PDB code 
2R8V). Vertebrate-like NAGS include the bifunctional bacterial NAGS/K, mammalian 
NAGS, fungal NAGS and other vertebrate NAGS, which have tetrameric architectures, 
represented by the bifunctional NAGS/K from Maricaulis maris (PDB code 3S6G). These 
two groups of NAGS are typical NAGS enzymes in that they have both AAK and NAT 
domains and catalyze the formation of NAG from AcCoA and glutamate. They are the 
focus of this review. ArgJ is the mono- or bi-functional ornithine acetyltransferase that 
catalyzes the production of NAG from acetylornithine and glutamate (mono-) and AcCoA 
and glutamate (bi-). This enzyme is likely to be a heterotetramer, represented by argJ from 
Mycobacterium tuberculosis (PDB code 3IT4). Other atypical NAGSs exist in certain 
bacteria but no structures have been determined so far. The short version of NAGS  
(S-NAGS), for example argA from M. tuberculosis has only NAT domain. The NAGS 
encoded by the argO gene of Campylobacter jejuni (O-NAGS) consists of 146 amino 
acids, which broadly relate to the GNAT family. H-NAGS has been identified in Moritella 
abyss and Moritella profunda with argH fused to the N-terminal end of the NAT related 
domain. C-NAGS is a novel type of NAGS, recently identified in Corynebacterium 
glutamicum, whose sequence does not have any relationship to other known NAGS. 
Synthesis of NAG can also be catalyzed by other proteins including argO encoded NAGS  
(O-NAGS) first identified in Campylobacter jejuni, S-NAGS, a short version of NAGS first identified 
in M. tuberculosis [24], and argH fused NAGS (H-NAGS) [7,25]. O-NAGS has only 146 amino  
acids [26] and although its sequence is related to the GNAT family, it does not have significant 
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similarity to the NAT domain of the typical NAGS. S-NAGS is able to catalyze the formation of NAG, 
but has an extremely high Km for glutamate [24]. H-NAGS, which includes a short version of NAGS 
fused to the C-terminus of argininosuccinate lyase (argH), has been found in some bacteria in the  
Alteromonas-Vibro group and is able to complement an argA E. coli mutant [27]. These enzymes have 
been reviewed in detail by Xu et al. [7]. More recently, a novel type of NAGS, the sequence of which 
is not related to any known NAGS, was identified in Corynebacterium glutamicum [25]. The variety of 
these enzymes raised the question of how and why proteins with such high divergence have the ability 
to catalyze the formation of the same compound, NAG. 
The acetylation of the α-amino group of glutamate was once thought to be the only way to  
prevent spontaneous cyclization of unprotected intermediates in the arginine biosynthetic pathway.  
The discovery of the novel N-succinyl-L-ornithine transcarbamylase indicates that different organisms 
may use different mechanisms to protect the α-amino group of glutamate [28,29]. Although the  
gene that encodes an enzyme that succinylates glutamate has not been identified, the identification of  
a GNAT-like succinyltransferase suggests that a similar enzyme will catalyze the succinylation 
reaction of glutamate [30]. Yet another mechanism for protecting the α-amino group of glutamate was 
identified when a small protein, LysW, was shown to also protect the α-amino group of glutamate by 
covalently linking the amino group of glutamate to the γ-carboxyl group of the terminal glutamate of 
LysW [31]. A RimK-like protein [32] encoded by ArgX (a homolog of LysX), with no sequence 
similarity to any known NAGS, catalyzes the above reaction. Notably, this mechanism was discovered in 
a member of the archaea, which use the same set of enzymes for L-lysine and L-arginine biosynthesis. 
This review will focus on the function, structures and mechanisms of the typical NAGS, which have 
been well characterized. Fifteen structures of these enzymes have been determined with seven in the  
bacteria-like NAGS group (PDB codes: 4I49, 3D2M, 3D2P, 2R8V, 2R98, 3B8G and 3E0K) and eight 
in the vertebrate-like NAGS group (4NEX, 4NF1, 4KZT, 4K30, 3S6H, 3S6G, 3S6K and 3S7Y).  
They include full-length and sub-domain structures, complexed with inhibitors as well as substrates.  
No NAGS structure from any fungi or plant has been determined until now, probably because of 
instability of most NAGS from other organisms. The structural information gleaned so far offers new 
insights into structure-function relationships as well as the catalytic and regulatory mechanisms. 
2. Early Biochemical Characterization of NAGS 
NAGS from E. coli (ecNAGS) is the best characterized member of the bacteria-like NAGS group. 
The protein has been purified to homogeneity and its biological and catalytic properties have been 
reported [8,9]. The enzyme seems to shift between trimeric and hexameric states depending on its 
concentration and the presence of ligands [8]. ecNAGS shows a relatively high substrate specificity 
towards L-glutamate and acetyl-CoA. Among the other amino acids tested, only L-glutamine and  
L-2-aminoadipate have acetylation activity of 6.8% and 1.3% of that of L-glutamate, respectively. 
Among the L-glutamate acyl donors that were tested, propionyl-CoA was the only other effective 
donor with 4.5% of the acetyl-CoA acylation rate [8]. 
The activity of ecNAGS is inhibited by L-arginine, with 50% activity reduction at 2 mM. ecNAGS 
is also inhibited, but to a lesser degree, by the reaction products NAG and CoA, with 50% inhibition at  
25 and 2.5 mM, respectively. Feedback inhibition by L-arginine was enhanced additively by CoA and 
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NAG, suggesting that L-arginine binds to the enzyme at a different site. Stabilization of the hexameric 
form of NAGS by NAG and L-arginine indicates that the regulation of the enzyme probably involves 
ligand-induced changes of its oligomerization state. 
Mammalian NAGS is found in the mitochondrial matrix of cells of the liver and intestines but not  
the kidney or spleen [33,34], and has been purified to apparent homogeneity from rat and human  
liver [12,13]. The molecular weight of the human holoenzyme is 190,000. Human liver NAGS affinity 
constants (Km) were reported as 4.4 mM for acetyl-CoA and 8.1 mM for L-glutamate [12], quite 
different from the values of 0.7 and 1 mM, respectively, for the rat enzyme [13]. The later numbers are 
in better agreement with recent biochemical studies on the recombinant enzymes [35]. 
Mammalian NAGS acetylates almost exclusively L-glutamate, with little activity with glutamine (5.0%) 
and glycine (2.9%) and no acetylation of other amino acids (<1.0%). L-glutamate-hydroxamate shows low 
activity as an acyl acceptor (15.5%), whereas no activity was found for L-glutamate-monoethyl ester  
and -hydrazide. Glutamate analogues that have longer carbon chains, such as DL-aminoadipate (5.2%) and 
DL-aminopimelate (4.0%), show low activity. The acetyl-CoA substrate is also very specific, showing 
low activity with propionyl-CoA (4.3%) and no activity with other acyl-CoA derivatives [13]. 
Enzymatic activity in the presence of saturating concentrations of substrates more than doubles  
(2–5-fold) in the presence of L-arginine with an activation constant (Ka) of 30–50 µM in vitro. Since no 
other amino acid has this activity and since the Ka is in the range of liver arginine concentrations  
in vivo [12–14,34,36], it is likely that arginine has a role in regulating NAG production. Arginine seems 
to increase the enzyme velocity without an effect on affinity for the substrates [37]. It is transported into 
mitochondria and therefore could activate NAGS in vivo [38]. The activation of NAGS by arginine seems 
to be very specific, since among the structural analogues of arginine, intermediates of the urea cycle, and 
amino acids, only L-argininic acid produces a similar activation [13]. Activation by argininic acid and 
arginine are not additive, implying that they probably bind to the same site. NAGS can also be 
activated by cationic polypeptides such as protamines, polyarginine and polylysine, but the activation 
is additive relative to that of arginine [13]. Mammalian NAGS appears to be a trimer but its 
oligomerization state seems to depend on the concentration of L-arginine [39]. These cationic 
polypeptide activators seem to stabilize the conformation of activated NAGS. A better understanding 
of arginine’s effect on NAGS activity could clarify its role in NAGS activation. 
3. Recent Biochemical Characterization of Recombinant NAGS 
Recently, Rubio’s group revisited the classical NAGS from Pseudomonas aeruginosa (paNAGS) 
using recombinant protein and mutagenesis techniques [10,39–41]. Gel filtration assays revealed that 
paNAGS exists in a non-dissociating hexamer regardless of the presence and absence of arginine. 
Mutation studies demonstrated that mutations of the site at which arginine is bound, specifically the  
C-terminal end of the AAK domain, did little to change the substrates’ kinetic parameters. The AAK 
and NAT domains can be expressed separately. The NAT domain has NAGS activity and is arginine 
insensitive even though the concentration of glutamate required for activity with the NAT domain  
alone was 25-fold higher than for full-length NAGS. Gel filtration experiments demonstrated that  
the AAK domain alone assembled as a hexamer, implying that the hexameric architecture of the  
full-length NAGS is nucleated by a hexamer ring of AAK domains that closely resembles the arginine 
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sensitive bacterial NAGK [42]. In contrast, the NAT domain probably exists as a monomer, although 
this needs to be further confirmed by additional experiments. Mutagenesis studies further demonstrated 
that the linker amino acids between the two domains are important for regulation of NAGS activity  
by arginine [41]. 
Because of the low sequence similarity between mammalian NAGS and classic bacterial NAGS, the 
gene that encodes mammalian NAGS was not identified until 2002 [15,16,43]. In addition to the AAK 
and NAT domains, mammalian NAGS has 40–50 additional amino acids at its N-terminus, termed  
the “variable domain” because of its low sequence similarity even among mammalian NAGS.  
The biochemical properties of mature NAGS (with variable domain but without mitochondrial target 
signal) and conserved NAGS (without variable domain and mitochondrial target signal) recombinant 
human and mouse proteins were compared [35]. The presence of 1 mM arginine enhances NAGS 
activity about twofold. More interestingly, conserved NAGS (without the variable domain) has 
twofold higher activity than mature NAGS (with the variable domain), in the presence of arginine. The 
variable domain is rich in charged amino acids and prolines, and likely devoid of secondary structure. 
Such unstructured domains are often important for protein–protein interactions. Whether and how the 
variable domain is involved in regulation of NAGS activity or interaction with other enzymes such as 
CPS1 needs to be further elucidated. 
4. Overview of the Structural Fold 
Determination of the crystal structures of NAGS from Neisseria gonorrhoeae (ngNAGS), which 
belongs to the classical bacteria-like NAGS group, and bifunctional NAGS/K structures from 
Maricaulis maris (mmNAGS/K) and Xanthomonas campestrics (xcNAGS/K), which belong to the 
vertebrate-like NAGS group including mammalian NAGS allows detailed structural characterization 
of each group possible. Even though there are significant sequence differences between the bacteria-like 
and vertebrate-like groups, both consist of two independent domains [44,45] (Figure 2A,B). 
Furthermore, the overall fold of each domain of these two groups of NAGS is very similar, although 
some differences exist. The N-terminal domain has typical the AAK domain with an eight-stranded β 
sheet as its central core and α helices hanging on both sides. The superimposition of AAK domains of 
mmNAGS and ngNAGS results in a root mean square deviation of 2.7 Å, with over 260 aligned 
residues. The most significant differences are identified in the N-terminal segment. The N-terminal 
segment of mmNAGS/K has two helices; in contrast, ngNAGS has only one as does arginine sensitive 
NAGK while arginine insensitive NAGK has no mobile N-terminal helix. The differences in their  
N-terminal segments appear to be highly correlated to their different subunit-subunit interactions  
and formation of different quaternary structures. The C-terminal has typical GNAT fold with a  
seven-stranded β sheet as its central core and three α helices hanging on both sides to form αβα 
sandwich structure. Superimposition of the NAT domain of mmNAGS/K and ngNAGS results in  
a root mean square deviation of 2.5 Å, with 112 aligned residues. Significant differences are found in 
the C-terminal arm. mNAGS/K has a much shorter loop to link β18 and β19 than ngNAGS, which has 
two extra helices (α14’ and α14) (Figure 2C). Instead, a long helix, α15, at the C-terminal of 
mmNAGS/K occupies the equivalent position of α14 in ngNAGS (Figure 2D). A 1–3 amino acid 
residue flexible linker fuses the two domains. The relative orientation between the two domains appears to 
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be affected by inhibitor binding and the different packing environments in crystal structures, and appears to 
be closely related to the regulation mechanism [44,46,47]. 
 
Figure 2. Ribbon diagram of subunit structures of ngNAGS and mmNAGS/K. (A) Subunit 
structure of ngNAGS in the absence of arginine. The structure consists of two domains, 
amino acid kinase (AAK) domain and N-acetyltransferase (NAT) domain, linked together 
by a flexible linker. No domain-domain interactions are observed within the subunit except 
via the linker; (B) Subunit structure of mmNAGS/K in the absence of arginine. The linker 
between AAK and NAT domains is shorter than that in ngNAGS. Some domain-domain 
interactions are observed. The structures are colored as a rainbow gradually changed from 
dark-blue for the N-terminus to red for the C-terminus; (C) Ribbon diagram of the NAT 
domain of ngNAGS. The bound CoA and NAG are shown in green and magenta sticks, 
respectively. Three residues, R416, R425 and S427, which are involved in binding NAG, 
are shown as green sticks; and (D) Ribbon diagram of NAT domain of mmNAGS/K. The 
last helix, α15, occupies the equivalent position of α14 of ngNAGS. Three residues, R386, 
R388 and N391, which are potentially involved in binding NAG, are shown as green 
sticks. The major differences in the NAT domains between ngNAGS and mmNAGS/K are 
colored in red. 
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5. Quaternary Structure of NAGS 
In NAGS from N. gonorrhoeae (ngNAGS), six subunits assemble via the N-terminal AAK domains 
with D3 symmetry to form a toroidal shaped structure with three NAT domains on one side and three 
NAT domains on the other side of the hexamer (Figure 3A). Although this is the only member of the 
bacteria-like NAGS group with a determined structure, it is likely conserved among members of this 
group. paNAGS has also been shown to be a hexamer in solution [10]. In contrast to the bacteria-like 
NAGS configuration represented by ngNAGS, the NAGS structures of M. maris and X. campestris  
are tetramers in which the AAK domains of the subunits are in the middle of the molecule and the 
NAT domains are at both polar ends (Figure 3B). The whole molecule has a D2 symmetry, which is 
different from ngNAGS. Although the protein sequences are highly diverse [17], the tetrameric 
structure seems to be a common feature among the vertebrate-like group. Consistent with this finding, 
NAGK from Saccharomyces cerevisiae, has a sequence similar to the vertebrate-like group and similar 
two-domain structures, as well as similar tetrameric quaternary structures [48]. 
AAK domains nucleate the quaternary structures of both bacteria-like and vertebrate-like NAGS 
through two different interfaces. The first interface involves the N-terminal segment. In ngNAGS, this 
interface (K1–K4 interface) is formed by interlacing the N-terminal helices from adjacent subunits 
(Figure 3C). In mmNAGS/K, the two helices in the N-terminus interact in parallel to two other 
equivalent helices from the adjacent subunits, to form this interface (K1–K2 interface) (Figure 3F). 
The second interface (K1–K5 in ngNAGS and K1–K3 in mmNAGS/K) involves the N-terminal lobe 
of the AAK domain. This subunit surface is commonly used to form the dimer structures in all other 
amino acid kinases, including E. coli NAGK [49], Pyrococcus furiosus UMP kinase [50], and E. coli 
glutamate 5 kinase [51]. However, the detailed interactions involving this interface are very different. 
Even though the two subunits involved in this interface are related to each other by two-fold 
symmetry, in both ngNAGS and mmNAGS/K, the two-fold symmetry axis is perpendicular to the 
plane of the central β-strand in ngNAGS, while it is parallel to the central β-strand in mmNAGS/K.  
In comparison to the equivalent subunit surface in ngNAGS, the subunit surface in mmNAGS  
has relative rotation about 117° between subunits around an axis perpendicular to the interacting 
surface (Figure 3D,G). 
In ngNAGS, no interaction between NAT domains from different subunits is found. Instead, the 
NAT domains interact with the AAK domains from the other subunits. This interaction (S1–K3 in 
ngNAGS) is weak but important for the regulation of NAGS activity (Figure 3E), because arginine 
binding changes this interface interaction completely. It is noteworthy that the structure of the  
C-terminal NAT domain without AAK domain from Vibrio parahaemolyticus (PDB code 3E0K) 
shows a domain swapped dimer. However, this dimer should not be biologically relevant because no 
such interactions were identified in the full-length structure in ngNAGS. In mmNAGS, the NAT 
domain interacts with the equivalent domain from adjacent subunit to form S1-S2 interface  
(Figure 3H). The pairing of NAT domains is involved in the antiparallel hydrogen bonding of the 
central β strands to form a continuing β-sheet, in addition to the hydrophobic interaction between 
helices from subunit 1 and 2. The dimer structure of NAT domains is maintained for the isolated NAT 
domain as well. The isolated C-terminal NAT domain from human and Xylella fastidiosa were recently 
shown to be a dimer in solution, and form the same dimer interface as the full-length mmNAGS/K in 
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the crystal structures [52,53]. This situation differs from the C-terminal DUF619 domain of scNAGK, 
in which the full-length structure shows very similar interactions of the C-terminal DUF619 domain, 
but, the isolated domain remains a monomer [48]. 
 
Figure 3. Quaternary structure and interface interactions of ngNAGS and mmNAGS/K. 
Simplified model of the hexamer architecture of ngNAGS (A) and the tetrameric 
architecture of mmNAGS/K (B). Ribbon diagram of three different types of interface for 
ngNAGS: K1–K4 interface (C), K1–K5 interface (D), and S1-K3 interface (E), in comparison 
to those of mmNAGS/K: K1–K2 interface (F), K1–K3 interface (G), and S1–S2 interface 
(H). K1–K4 and K1–K5 interfaces of ngNAGS have two-fold symmetry, whose axes, 
indicated by a blue oval, are perpendicular to the plane. As a result, in K1–K5 interface the 
central β5 interacts with the equivalent β5 from another subunit in an antiparallel fashion to 
form a continuous β strand across this interface. No symmetry exists for S1–K3 interface 
of ngNAGS, which will change upon arginine binding to enzyme. All three types of 
interfaces of mmNAGS/K have a two-fold symmetry, indicated by blue arrows, which are 
parallel to the plane. As a result, the central β3 positions with the equivalent β3 from other 
subunit in a parallel fashion in K1–K3 interface of mmNAGS/K, which is different from 
that in ngNAGS. The central β18 interacts with the equivalent β18 from another subunit 
antiparallel in S1–S2 interface of mmNAGS/K, forming a continuous β strand across the 
interface. No equivalent interface is found in ngNAGS. 
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6. Active Site and Catalytic Mechanism 
Since the short NAGS without the N-terminal domain of NAGS displays an extremely high Km for 
glutamate [10,24], it was speculated previously that an efficient glutamate binding site might be 
provided by the AAK domain [7,42]. It is now clear, however, that both substrates, AcCoA and 
glutamate, bind in the NAT domain. Even though the sequence similarity for the NAT domain in 
ngNAGS and mmNAGS is low (15% sequence identity), both AcCoA and glutamate bind in a similar 
location within the cleft of the V-shaped GNAT fold [44,45,52–54]. The unique characteristics of the 
CoA recognition motif, which conforms to the (Arg/Gln)-Xaa-Xaa-Gly-Xaa-(Gly/Ala), can be seen in 
all ngNAGS, mmNAGS/K and human NAGS. The AcCoA and CoA bound ngNAGS structures 
clearly demonstrate that the S-acetylpantetheine moiety of AcCoA forms a pseudo-antiparallel β-sheet 
interaction with β22, and the pyrophosphate moiety interacts with the CoA recognition motif (Figure 2C). 
Even though no AcCoA or CoA bound structures of vertebrate-like NAGS are available, probably due 
to weaker affinity for AcCoA compared to bacteria-like NAGS, it is believed that AcCoA binds to the 
enzyme in a way similar to its binding to ngNAGS and other Gcn5-related acetyltransferases. 
The NAG bound structures of both ngNAGS and human NAGS enable the glutamate binding sites to 
be characterized in detail. A comparison of NAG bound structures of ngNAGS and hNAGS is shown in 
Figure 4A,B. The acetyl and the α-amino groups of NAG bind to the protein in a very similar way for  
both ngNAGS and hNAGS. However, the α-carboxyl and γ-carboxyl groups of NAG are in different  
locations and use different sets of amino acid residues to anchor to the protein. In ngNAGS, the  
side-chains of Arg316, Arg425 and Ser427, in addition to the main-chain N of Leu314 and Cys356, are 
involved in binding the two carboxyl groups. In hNAGS, the side-chains of Lys401, Arg474, Arg476 
and Asn479 contribute hydrogen-bonding interactions for positioning the carboxyl groups. Two  
water-mediated interactions with the side-chain of Tyr441 and the main-chain N of Ser524 are also 
involved in binding the α carboxyl group. The NAG binding cavity of hNAGS appears to be larger  
than that of ngNAGS. The recently available structure of the NAT domain alone of xfNAGS/K bound  
with NAG demonstrate that NAG can bind to the protein in two different conformations, implying that  
the glutamate binding site for vertebrate-like NAGS might have more plasticity than its counterpart in  
bacteria-like NAGS [53]. 
The structures of ngNAGS bound with CoA and NAG, and with the bisubstrate-like analog,  
CoA-S-acetyl-L-Glu, suggest that the enzyme uses a direct attack mechanism to catalyze the  
reaction [45,54]. The similarities of the AcCoA and glutamate binding sites to those of ngNAGS imply 
that the vertebrate-like NAGS uses the same catalytic mechanism. In order for the α amino group of 
glutamate to attack the carbon atom of the acetyl group of AcCoA, a general base to facilitate the 
depronation of the α-amino group is usually needed. In ngNAGS, Glu353 was proposed to play this  
role [54]. In hNAGS, Tyr441 was proposed to play the similar role. The equivalent Tyr353 in 
mmNAG/K, Tyr361 in xcNAGS/K and Tyr352 in xfNAGS/K, can be identified as well [53].  
After formation of the tetrahedral intermediate, a general acid to assist the protonation of the releasing 
CoA may also be required. In most of Gcn5 acetyltransferases, a tyrosine can be found to play this role 
including in vertebrate-like NAGS (Tyr485 in hNAGS and Tyr397 in mmNAGS/K) [52,53,55]. 
However, in ngNAGS, no such equivalent tyrosine residue is found, instead, the nearby Ser392 
replaces it as a general acid [54]. 




Figure 4. NAG binding site of ngNAGS (A) and hNAGS (B). The protein is shown in 
ribbon diagram. The bound NAG is shown as thick cyan sticks. The residues involved in 
binding NAG are shown as sticks. The hydrogen bonds are shown as red dashed lines. 
NAG binds to the protein in different conformations and using different sets of amino acid 
residues in ngNAGS and hNAGS. 
7. Arginine Binding Site and Regulatory Mechanism 
Structural and mutagenesis studies show that the arginine-binding site of NAGS and arginine 
sensitive NAGK is conserved across phyla [42,46,47,56]. The arginine-binding site is located at the  
C-terminus of the AAK domain, close to the AAK and NAT domain interface and the C-terminal 
segment of the N-terminal helix of protein (helix 1 in ngNAGS, helix 2 in mmNAGS/K)  
(Figure 5A,B). The primary sequence has a conserved motif of E-(L/I)-(F/M)-(T/S)-X-X-G-X-G-T [56], 
which forms a loop connecting the last helix and the last β strand of the AAK domain.  
The arginine binds to the protein in such a way as to place the Cα on the N-terminal helix,  
the α-carboxyl group towards the central β-sheet and the side-chain to be encircled by the loop. A key 
lysine from the central β-sheet (K201 in ngNAGS and K206 in mmNAGS/K) and a key glutamate 
from the last helix of AAK domain (E270 in ngNAGS and E277 in mmNAGS/K) with many  
main-chain oxygen atoms help to position arginine in this position (Figure 5C,D). 
The ngNAGS and mmNAGS/K structures with and without arginine bound provide significant 
insights into arginine induced regulation mechanisms [44–47]. In ngNAGS, arginine binding tightens 
its site and triggers the N-terminal helix movement to enhance K1–K5 interface interaction. As a 
result, the conformation of the whole hexamer changes significantly with a ~20 Å contraction along its 
three-fold axis and ~10 Å expansion for its hexamer ring (Figure 5E). The magnitudes of these 
changes are comparable with those found in arginine-sensitive NAGK structures [42], implying that 
arginine induced global conformational changes depend on the AAK domain only. As the hexamer 
ring widens, the linker between the AAK and NAT domains tightens, trigging a significant changes in 
the relative orientation of the NAT and AAK domains, re-establishing the K3-S1 interface interaction 
(Figure 5F). Eventually, the glutamate binding loops (helix10–helix11 and helix14-β25) become 
disordered and less able to bind the substrate. Mutagenesis and biochemical studies are consistent with this 
regulatory mechanism. The presence of arginine mainly affects the Km for glutamate and the elongation of 
the linker between AAK and NAT domains completely abolishes the arginine inhibition [41]. In the 
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absence of an AAK domain, as in the short NAGS from Mycobacterium tuberculosis, the Km of 
glutamate can be as high as 600 mM [24]. 
 
Figure 5. Arginine binding site and conformational changes. (A) Ribbon diagram of 
subunit structure of ngNAGS in the presence of arginine; (B) Ribbon diagram of subunit 
structure of mmNAGS/K in the presence of arginine. Arginine is shown in space filling 
model; (C) The details of arginine binding site of ngNAGS; (D) The details of arginine 
binding site of mmNAGS/K. The arginine and key residues involved in binding arginine 
are shown in sticks; (E) Simplified model of quaternary structure in the presence of arginine; 
and (F) The K3-S1 interface of ngNAGS in the presence of arginine. 
mmNAGS/K and other vertebrate-like NAGS have tetrameric structures that are totally different 
from bacteria-like NAGS and the arginine regulation mechanism appears to be quite different. In the 
absence of arginine, the relative orientation between the AAK and NAT domains in vertebrate-like 
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NAGS is quite flexible. The difference of the orientation angle can be as large as 29° between open 
and closed conformations [44]. In the presence of arginine, the subunit is in the closed conformation, 
which blocks AcCoA binding and therefore inhibits NAGS activity (Figure 5B) [47]. Interestingly, the 
relative orientation differences between AAK and NAT domains in the mature scNAGK structure for 
different subunits are up to 55°, reflecting similar conformational plasticity. Although the structure of 
mature hNAGS has not yet been determined, hNAGS and mNAGS both exist as tetramers in solution 
and pairing of the NAT domains is similar and thus it seems likely that the molecular mechanism of 
arginine activation is similar [52]. The respective domains are close only to a certain degree to promote 
catalytic activity, rather than to completely block the AcCoA binding site to inhibit it. The arginine titration 
curve of xcNAGS/K gave some clues for the mechanism. In the presence of very low concentration of 
arginine (<0.1 mM), arginine enhances NAGS activity about 20%, even though higher concentration of 
arginine inhibits NAGS activity completely by blocking the AcCoA binding site [17,52]. 
8. Evolution of Primary and Quaternary Structures 
Phylogenetic analysis has shown that classical bacteria and plant NAGS cluster in one group while 
bifunctional NAGS/K, fungal NAGK and NAGS, and vertebrate NAGS cluster in another large  
group [17]. The different quaternary structures of representative members of each group are consistent 
with the distant relationship between these two groups, implying that the separation of these two 
groups is a very early evolutionary event, as predicted previously [57]. However, the conservation of 
the arginine binding site and the general folding of the AAK domain indicate that the domains of  
both groups may be derived from the same common ancestor. The low sequence similarity and  
the non-conservation of the glutamate binding site in the NAT domains of the two groups demonstrate 
either that the NAT domains for different groups may come from different ancestors or that  
the separation of their NAT domains is likely a much earlier event before they fused with AAK 
domain to form NAGS. In the vertebrate-like NAGS group, the bifunctional NAGS/K appears to be 
the progenitor of other members positioned close to the root of the phylogenetic tree [17]. 
Interestingly, the bacteria whose genomes encode bifunctional NAGS/K also encode the gene for  
N-acetyl-L-ornithine transcarbamylase (AOTCase) in the arginine biosynthetic pathway, suggesting  
a coevolution of these two genes [17]. Phylogenetic analysis of the transcarbamylase family showed 
that the group of AOTCase clustering with N-succinyl-L-ornithine transcarbamylase [29] and YgeW 
encoded transcarbamylase of unknown function [58] is close to the root of the tree [59].  
The primordial bifunctional NAGS/K evolved further to become the present day vertebrate NAGS, 
fungal NAGS and NAGK. The vertebrate NAGS and fungal NAGS preserved acetyltransferase 
activity, but lose the kinase activity while the fungal NAGK does the opposite. However, the present 
day fungal NAGK is formed by proteolytic processing of the biprotein precursor encoded by fusing an 
additional down-stream gene, argC [60,61]. Searches of the bacterial genomes reveal that the NAGS 
gene found in some bacteria appears to be the vestiges during this evolution. In the Azospirillum sp. 
B510 genome, the NAGS gene (AZL_c01370 is incorrectly annotated as argC, since argC encodes  
N-acetyl-γ-glutamyl-phosphate reductase), which has close sequence similarity with human (41.8%) 
and xcNAGS/K (76.7%), has lost its NAGK activity as a result of the elimination of key residues in 
the NAGK active site (R66D, N158G, K217T, E. coli NAGK numbering). Instead, a protein encoded by  
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a different gene (AZL_005260) performs the NAGK function. In the Haliangium ochraceum genome, 
where there is a separate gene (Hoch_4935) for a bacterial-type NAGK, the gene for NAGS appears fused 
to the argC gene for N-acetyl-γ-glutamyl-phosphate reductase. Thus, this gene (Hoch_4300, incorrectly 
annotated as argC only) resembles the yeast gene encoding NAGK and N-acetyl-γ-glutamyl-phosphate 
reductase. Whether this protein in H. ochraceum undergoes proteolytic processing to cleave the argC 
domain as in yeast remains to be determined. The evolutionary paths of the typical NAGS are summarized 
in Figure 6. 
 
Figure 6. Proposed evolutionary path of the bacteria-like and vertebrate-like NAGS.  
The domains that have and have not enzymatic activity are colored green and red, 
respectively. The genes for fungal NAGK and Haliangium ochraceum NAGS (marked  
with *) encode a three-domain preprotein, whose mature proteins are formed likely by 
cleaving the argC domain. 
9. Concluding Remarks 
As a result of convergent evolution, many proteins have the capacity to catalyze the production of 
NAG from AcCoA and glutamate. Many more studies are needed to elucidate how these proteins bind 
substrates, whether they use the same catalytic mechanisms, where arginine binds and how arginine 
regulates their activity. The current knowledge about structure-function relationship is derived mainly 
from the two major groups of NAGS, bacteria-like and vertebrate-like. They are both two-domain 
proteins with an AAK domain at the N-terminus and a NAT domain at the C-terminus. Even though 
only the NAT domain has significant NAGS activity, the AAK domain provides the structural 
architecture for the enhancement of NAGS activity and for arginine binding and regulation. In 
mammalian counterparts, there is an extra N-terminal variable segment in addition to the AAK 
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domain. This segment may be involved in protein-protein interactions with other mitochondrial protein 
partners [52]. Currently, little is known about the function and structure of H-NAGS. Whether argH 
plays a similar role to the AAK domain in the typical NAGS remains to be established. The possibility 
that the short version of NAGS (S-NAGS) and O-NAGS interact with other protein partners in vivo 
cannot be ruled out without further experiments. The recent discovery of a novel type of NAGS  
(C-NAGS) provides a new and fascinating opportunity to explore how different structures can catalyze 
the same reaction [25]. 
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